Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.

Gillessena, Silke; Attard, Gerhardt; Beer, Tomasz; Beltran, Himisha; Bjartell, Anders; Bossi, Alberto; Briganti, Alberto; Bristow, Rob; Chi, Kim; Clarke, Noel; Davis, Ian; de Bono, Johann; Drake, Charles; Duran, Ignacio; Eeles, Ros; Efstathiou, Eleni; Evans, Christopher; Fanti, Stefano; Feng, Felix; Fizazi, Karim; Frydenberg, Mark; Gleave, Martin; Halabi, Susan; Heidenreich, Axel; Heinrich, Daniel; Higano, Celestia; Hofman, Michael; Hussain, Maha; James, Nicolas; Kanesvaran, Ravindran; Kantoff, Philip; Khauli, Raja; Leibowitz, Raya; Logothetis, Chris; Maluf, Fernando; Millman, Robin; Morgans, Alicia; Morris, Michael; Mottet, Nicolas; Mrabti, Hind; Murphy, Declan; Murthy, Vedang; Oh, William; Ost, Piet; OSullivan, Joe; Padhani, Anwar; Parker, Chris; Poon, Darren; Pritchard, Colin; Reiter, Robert; Roach, Mack; Rubin, Mark; Ryan, Charles; Saad, Fred; Sade, Juan; Sartor, Oliver; Scher, Howard; Shore, Neal; Small, Eric; Smith, Matthew; Soule, Howard; Sternberg, Cora; Steuber, Thomas; Suzuki, Hiroyoshi; Sweeneyh, Christopher; Sydes, Matthew; Taplinh, Mary-Ellen; Tombal, Bertrand; Turkeri, LEVENT; van Oort, Inge; Zapatero, Almudena; Omlind, Aurelius

doi:10.1016/j.eururo.2020.01.012

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.

Atıf İçin Kopyala

Gillessena S., Attard G., Beer T. M., Beltran H., Bjartell A., Bossi A., ...Daha Fazla

European urology, cilt.77, sa.4, ss.508-547, 2020 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 77 Sayı: 4
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.eururo.2020.01.012
Dergi Adı: European urology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, EMBASE, Gender Studies Database, MEDLINE
Sayfa Sayıları: ss.508-547
Anahtar Kelimeler: Advanced prostate cancer, High-risk localised prostate cancer, Hormone-sensitive prostate cancer, Castration-resistant prostate cancer, Oligometastatic prostate cancer, Progression-free survival, Overall survival, Prostate cancer treatment, Imaging, Genetics, Tumour genomic profiling, ANDROGEN-DEPRIVATION THERAPY, SALVAGE RADIATION-THERAPY, QUALITY-OF-LIFE, HOT FLASHES, RADICAL PROSTATECTOMY, CLINICAL-TRIALS, FREE SURVIVAL, PHASE-III, TESTOSTERONE MEASUREMENTS, ABIRATERONE ACETATE
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Background: Innovations in treatments, imaging, and molecular characterisation in advanced prostate cancer have improved outcomes, but there are still many aspects of management that lack high-level evidence to inform clinical practice. The Advanced Prostate Cancer Consensus Conference (APCCC) 2019 addressed some of these topics to supplement guidelines that are based on level 1 evidence.